Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design.
Rejdak K, Fiedor P, Bonek R, Goch A, Gala-Błądzińska A, Chełstowski W, Łukasiak J, Kiciak S, Dąbrowski P, Dec M, Król ZJ, Papuć E, Zasybska A, Segiet A, Grieb P. Rejdak K, et al. Among authors: zasybska a. Contemp Clin Trials. 2022 May;116:106755. doi: 10.1016/j.cct.2022.106755. Epub 2022 Apr 4. Contemp Clin Trials. 2022. PMID: 35390511 Free PMC article.
Amantadine in unvaccinated patients with early, mild to moderate COVID-19: A randomized, placebo-controlled, double-blind trial.
Rejdak K, Fiedor P, Bonek R, Łukasiak J, Chełstowski W, Kiciak S, Dąbrowski P, Gala-Błądzińska A, Dec M, Papuć E, Zasybska A, Kaczor M, Grieb P; COV-PREVENT Study Group. Rejdak K, et al. Among authors: zasybska a. Eur J Neurol. 2024 Jan;31(1):e16045. doi: 10.1111/ene.16045. Epub 2023 Sep 14. Eur J Neurol. 2024. PMID: 37584095 Clinical Trial.